Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
about
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsOrthopox Viruses: Infections in HumansProteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses.Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.Development of ST-246® for Treatment of Poxvirus Infections.Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia VirusNonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246.ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestationCamelpox: epidemiology, diagnosis and control measures.The strategic use of novel smallpox vaccines in the post-eradication world.Challenges and Achievements in Prevention and Treatment of Smallpox.Anti-DNA Virus AgentsEmerging antiviral drugs
P2860
Q28384852-1CE01611-0504-4455-A267-FDDE26AF07D4Q28742218-F7592372-9333-4F6E-8A79-4015546B04B1Q33447166-32D169FD-96C4-4624-A527-F3DF4219CC9AQ34502253-FD15BBC4-F55B-4E6A-97BD-69FF3E422A67Q35152092-86081FE7-896F-4293-B098-B91A0B9C3297Q35260385-7E610D6B-8348-449B-B7D8-82E1AD8DC14FQ35745996-A3263795-2D9F-46A6-A9A6-99A68F110BBFQ35760869-BFD7753E-3399-4316-A1F6-A422186CB73AQ36281104-FE9ADCDA-77D7-42EF-A8F6-3351B9F2C41BQ37204210-2A05B381-1342-440C-B1B4-5516D93F14B7Q37450819-78AE2C3C-AA64-4C4D-B69D-2058D6900A62Q37800922-CA913854-3DA5-458E-9CFD-06DE45C61F08Q37909421-AC992707-8C0A-49AA-9E9D-6ECB1371D207Q47547852-14E4AA8B-91B0-4690-9DE5-5C2100459071Q56786267-5D9D5A9B-D206-404D-B4FC-495138C671F5Q56786308-16660E2B-F294-41B6-AAB8-BDDB7F2E410F
P2860
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune responses to the smallp ...... tor of poxvirus dissemination.
@en
Immune responses to the smallp ...... tor of poxvirus dissemination.
@nl
type
label
Immune responses to the smallp ...... tor of poxvirus dissemination.
@en
Immune responses to the smallp ...... tor of poxvirus dissemination.
@nl
prefLabel
Immune responses to the smallp ...... tor of poxvirus dissemination.
@en
Immune responses to the smallp ...... tor of poxvirus dissemination.
@nl
P2093
P2860
P1433
P1476
Immune responses to the smallp ...... tor of poxvirus dissemination.
@en
P2093
Aklile Berhanu
Dana L Kirkwood-Watts
David S King
Dennis E Hruby
Douglas W Grosenbach
Kevin F Jones
Rebecca L Wilson
Shanthakumar Tyavanagimatt
Travis K Warren
P2860
P304
P356
10.1016/J.VACCINE.2007.11.095
P407
P577
2007-12-26T00:00:00Z